FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422988009: Bismuth biskalcitrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2640344010 Bismuth biskalcitrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2644399011 Bismuth biskalcitrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2640344010 Bismuth biskalcitrate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2640344010 Bismuth biskalcitrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2644399011 Bismuth biskalcitrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2644399011 Bismuth biskalcitrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
193221000077119 biskalcitrate de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193221000077119 biskalcitrate de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bismuth biskalcitrate (substance) Is a Bismuth compound true Inferred relationship Existential restriction modifier (core metadata concept)
Bismuth biskalcitrate (substance) Is a Antacid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Bismuth biskalcitrate + metornidazole + tetracycline The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing bismuth biskalcitrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has precise active ingredient False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only bismuth biskalcitrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has precise active ingredient False Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Bismuth biskalcitrate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3

This concept is not in any reference sets

Back to Start